Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Clin Cancer Res ; 15(5): 1830-6, 2009 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-19240171

RESUMO

PURPOSE: Photodynamic therapy (PDT) is used to treat Barrett's esophagus with high-grade dysplasia and mucosal carcinoma. Outcomes are variable with some patients having persistent disease, whereas others develop strictures. The aims of this study were (a) to compare porfimer sodium tissue uptake, light dose, and esophageal thickness with clinical outcomes and (b) to determine the selectivity of porfimer sodium uptake in diseased and normal epithelium. EXPERIMENTAL DESIGN: Forty-eight hours after porfimer sodium infusion, patients underwent mucosal biopsy for quantification of the porfimer sodium. Laser light was delivered at 48 hours and again 24 or 48 hours later. Porfimer sodium was extracted from the biopsy samples and quantified using fluorescence spectroscopy. The enhanced photodynamic dose was determined as [porfimer sodium content * light dose/esophageal thickness]. PDT efficacy was determined 6 to 8 weeks later based on persistence or complete ablation of dysplasia or carcinoma. RESULTS: Mean porfimer sodium content of 6.2 mg/kg (range, 2.6-11.2 mg/kg) and mean total light dose of 278 J/cm (range, 225-360 J/cm) resulted in a complete treatment. Mean porfimer sodium tissue content of 3.9 mg/kg (range, 2.1-8.1 mg/kg) and mean total light dose of 268 J/cm (range, 250-350 J/cm) resulted in an incomplete treatment. The total esophageal thickness (range, 1.7-6.0 mm) and enhanced photodynamic dose were correlated with treatment outcome. CONCLUSIONS: Esophageal thickness is the strongest predictor of treatment outcome. The porfimer sodium content of Barrett's and normal tissue is not significantly different. "Photodynamic dose" for esophageal PDT should incorporate the esophageal thickness.


Assuntos
Esôfago de Barrett/tratamento farmacológico , Éter de Diematoporfirina/administração & dosagem , Neoplasias Esofágicas/tratamento farmacológico , Fotoquimioterapia , Fármacos Fotossensibilizantes/administração & dosagem , Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/secundário , Idoso , Idoso de 80 Anos ou mais , Esôfago de Barrett/patologia , Biópsia , Éter de Diematoporfirina/farmacologia , Relação Dose-Resposta à Radiação , Neoplasias Esofágicas/patologia , Humanos , Luz , Pessoa de Meia-Idade , Fármacos Fotossensibilizantes/farmacologia , Projetos Piloto , Radiometria , Resultado do Tratamento
2.
Photochem Photobiol ; 85(1): 341-6, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19161398

RESUMO

Photodynamic therapy (PDT) is FDA-approved for use in patients with Barrett's esophagus using porfimer sodium (2 mg per kg) and a recommended light dose of 130 J cm(-1) for high grade dysplasia. Despite uniform drug and light doses, the clinical outcome of PDT is variable. A significant number of PDT cases result in esophageal strictures, a side effect related to excessive energy absorption. The purpose of this project was to model esophageal stricture formation with a Monte Carlo simulation. An original multilayer Monte Carlo computer simulation was developed for esophageal PDT. Optical absorption and scattering coefficients were derived for mucosal and muscle layers of normal porcine esophagus. Porfimer sodium was added to each layer by increasing the absorption coefficient by the appropriate amount. A threshold-absorbed light dose was assumed to be required for stricture formation and ablation. The simulation predicted irreversible damage to the mucosa with a 160 J cm(-1) light dose and damage to the muscle layer with an additional 160 J cm(-1) light dose for a tissue porfimer sodium content of 3.5 mg kg(-1). The simulation accurately modeled photodynamic stricture formation in normal pig in vivo esophageal tissue. This preliminary work suggests that the absorbed light threshold for stricture formation may be between 2 and 4 J per gram of tissue.


Assuntos
Esôfago/efeitos da radiação , Modelos Biológicos , Sus scrofa , Animais , Difusão , Esôfago/efeitos dos fármacos , Método de Monte Carlo , Fotoquimioterapia , Fármacos Fotossensibilizantes/farmacologia
3.
Arch Intern Med ; 169(18): 1668-76, 2009 Oct 12.
Artigo em Inglês | MEDLINE | ID: mdl-19822823

RESUMO

BACKGROUND: Major depressive disorder (MDD) is associated with coronary heart disease (CHD), but the mechanisms are unclear. The presence of MDD may increase CHD risk by affecting microvascular circulation. It is also plausible that genetic factors influencing MDD may overlap with those for CHD. We sought to examine the relationship between MDD and coronary flow reserve (CFR), the ratio of maximum flow during stress to flow at rest measured in milliliters per minute per gram of tissue. METHODS: We examined 289 male middle-aged twins, including 106 twins (53 twin pairs) discordant for a lifetime history of MDD and 183 control twins (unrelated to any twins in the experimental group) without MDD. To calculate CFR, we used positron emission tomography with nitrogen 13 ((13)N) ammonia to evaluate myocardial blood flow at rest and after adenosine stress. A standard perfusion defect score was also used to assess myocardial ischemia. RESULTS: There was no difference in myocardial ischemia between twins with and without MDD. Among the dizygotic twin pairs discordant for MDD, the CFR was 14% lower in the twins with MDD than in their brothers without MDD (2.36 vs 2.74) (P = .03). This association was not present in the monozygotic discordant pairs who were genetically matched (2.86 vs 2.64) (P = .19). The zygosity-MDD interaction after adjustment was significant (P = .006). The CFR in the dizygotic twins with MDD was also lower than in the control twins. CONCLUSIONS: Our results provide evidence for a shared genetic pathway between MDD and microvascular dysfunction. Common pathophysiologic processes may link MDD and early atherosclerosis.


Assuntos
Circulação Coronária , Transtorno Depressivo Maior/fisiopatologia , Doenças em Gêmeos/fisiopatologia , Doença da Artéria Coronariana/genética , Doença da Artéria Coronariana/fisiopatologia , Estudos Transversais , Transtorno Depressivo Maior/genética , Doenças em Gêmeos/genética , Predisposição Genética para Doença , Coração/diagnóstico por imagem , Humanos , Masculino , Pessoa de Meia-Idade , Isquemia Miocárdica/genética , Isquemia Miocárdica/fisiopatologia , Estresse Oxidativo , Tomografia por Emissão de Pósitrons , Gêmeos Dizigóticos , Gêmeos Monozigóticos
4.
Appl Opt ; 43(14): 2846-60, 2004 May 10.
Artigo em Inglês | MEDLINE | ID: mdl-15143808

RESUMO

Fiber-optic probes are widely used in optical spectroscopy of biological tissues and other turbid media. Only limited information exists, however, on the ways in which the illumination-collection geometry and the overall probe design influence the interrogation of media. We have investigated both experimentally and computationally the effect of probe-to-target distance (PTD) on the diffuse reflectance collected from an isotropically (Lambertian) scattering target and an agar-based tissue phantom. Studies were conducted with three probes characterized by either common (single-fiber) or separate (two bifurcated multifiber probes) illumination and collection channels. This study demonstrates that PTD, probe design, and tissue scattering anisotropy influence the extent of the transport of light into the medium, the light-collection efficiency, and the sampling volume of collected light. The findings can be applied toward optimization of fiber-optic probe designs for quantitative optical spectroscopy of turbid media including biological tissues.


Assuntos
Análise de Falha de Equipamento/métodos , Tecnologia de Fibra Óptica/instrumentação , Microscopia de Fluorescência/instrumentação , Microscopia Ultravioleta/instrumentação , Modelos Biológicos , Espectrometria de Fluorescência/instrumentação , Espectrofotometria Ultravioleta/instrumentação , Transdutores , Simulação por Computador , Desenho Assistido por Computador , Tecido Conjuntivo/metabolismo , Tecido Conjuntivo/ultraestrutura , Desenho de Equipamento/métodos , Microscopia de Fluorescência/métodos , Microscopia Ultravioleta/métodos , Fibras Ópticas , Imagens de Fantasmas , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Espectrometria de Fluorescência/métodos , Espectrofotometria Ultravioleta/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA